Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
BioNTech AG
BioNTech AG
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
ISPE announces 2024 Facility of the Year Awards category winners
The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Finance
BioNTech and Autolus announce strategic collaboration
The strategic collaboration will advance both companies' autologous CAR-T programmes towards commercialisation, pending regulatory authorisations
Manufacturing
AGC to support Pfizer-BioNTech Omicron vaccine
Plasmid DNA from AGC is already supplied as a starting material for the companies' COVID-19 vaccine
Ingredients
Pfizer and BioNTech announce early positive vaccine update
Collaboration has announced results from German Phase 1/2 COVID-19 vaccine study, including first T-Cell response data
Finance
BioNTech completes acquisition of Neon Therapeutics
Biopharmaceutical New Technologies (BioNTech) is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases
Research & Development
BioNTech and Pfizer dose first cohort of Phase I/II COVID-19 vaccine trial
The trial is the first clinical trial of a COVID-19 vaccine candidate in Germany and there are plans to initiate trials in the US upon regulatory approval
Research & Development
Sanofi and BioNTech sign cancer immunotherapy partnership
BioNTech could receive more than US$300m in development, regulatory and commercial milestones
Research & Development
BioNTech and Siemens cooperate on production of personalised cancer vaccines
Siemens will develop and construct an automated and paperless manufacturing site
Subscribe now